FDA clears Toshiba flat panel
The way is clear for Toshiba America Medical Systems to begin integrating a flat-panel detector into its Infinix-i series of vascular imaging systems. The detector, which offers an 8-inch-square (20 cm x 20 cm) field-of-view, has passed FDA review for
The way is clear for Toshiba America Medical Systems to begin integrating a flat-panel detector into its Infinix-i series of vascular imaging systems. The detector, which offers an 8-inch-square (20 cm x 20 cm) field-of-view, has passed FDA review for use in high-resolution dynamic imaging. The flat panel will be integrated into new Infinix systems as well as units in the installed base. Swapping the flat panel for image intensifiers onboard Infinix-i systems will take about three days, according to the company. The Infinix-i series comes in single-, bi-, and dual-plane configurations.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
What if Radiology Turns Out Exactly the Way We Predict it Will?
May 19th 2025Whether it is reimbursement cuts or continued attempts to push non-radiologist image interpretation, where do we draw the line between inspired protest and misspent energy criticizing things that are doomed to fail or things we have no control over?
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.
